Medicine
Date:
06/05/2020
The University’s Stem Cell Institute (SCI), an interdisciplinary center that was the first such academic institute in the U.S., celebrates its 20th anniversary in 2020. Several SCI researchers, including its first director, Dr. Catherine Verfaillie, are or have been MSI PIs. A story about the SCI featuring several current MSI PIs appears in the Spring 2020 issue of the Medical School’s publication Medical Bulletin: Stem Cell Ingenuity.
The PIs appearing in the article are:
- Professor Brenda Ogle (Biomedical Engineeering; Head, Stem Cell Institute)
- Professor Ogle uses MSI for single-cell RNA-seq for research to obtain a global view of phenotypic diversification of mesenchymal stem cell-parenchymal hybrids and associated time course.
- Professor Jakub Tolar (Dean, Medical School; VP for Clinical Affairs, UMN)
- Professor Tolar uses MSI to analyze RNA-seq data related to research into the skin environment of patients with Recessive Dystrophic Epidermolysis Bullosa (RDEB).
- Associate Professor Rita Perlingeiro (Medicine)
- Professor Perlingeiro uses MSI resources to analyze RNA-seq and ChIP-seq studies related to research involving generating skeletal muscle progenitors from embryonic stem cells.
- Assistant Professor Ann Parr (Neurosurgery)
- Professor Parr uses MSI to support research into developing optimal stem-cell transplantation therapies for chronic spinal cord injury.